Attached files
| file | filename |
|---|---|
| EX-31.B - CERTIFICATION OF CFO REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) - Avanos Medical, Inc. | hyh2017form10kex31b.htm |
| EX-32.B - CERTIFICATION OF CFO REQUIRED BY RULE 13A-14(B) OR RULE 15D-14(B) - Avanos Medical, Inc. | hyh2017form10kex32b.htm |
| EX-32.A - CERTIFICATION OF CEO REQUIRED BY RULE 13A-14(B) OR RULE 15D-14(B) - Avanos Medical, Inc. | hyh2017form10kex32a.htm |
| EX-31.A - CERTIFICATION OF CEO REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) - Avanos Medical, Inc. | hyh2017form10kex31a.htm |
| EX-24 - EXHIBIT 24 - Avanos Medical, Inc. | hyh2017form10kex24.htm |
| EX-21 - EXHIBIT 21 - Avanos Medical, Inc. | hyh2017form10kex21.htm |
| EX-12 - EXHIBIT 12 - Avanos Medical, Inc. | hyh2017form10kex12.htm |
| 10-K - FORM 10-K - Avanos Medical, Inc. | hyh2017form10k.htm |
Exhibit No. 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement No. 333-199748 on Form S-8 of our reports dated February 27, 2018, relating to the consolidated financial statements of Halyard Health, Inc. and subsidiaries, and the effectiveness of Halyard Health, Inc. and subsidiaries' internal control over financial reporting, appearing in this Annual Report on Form 10-K of Halyard Health, Inc. for the year ended December 31, 2017.
/s/ DELOITTE & TOUCHE LLP |
Deloitte & Touche LLP |
Atlanta, Georgia |
February 27, 2018 |